Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH/Publishers Meet On Open Access; Six-Month Schedule Is Key Concern

This article was originally published in The Pink Sheet Daily

Executive Summary

Publishers maintain free access to research six months after publication could destroy small scientific societies that publish their journals bimonthly or quarterly. Delegation raises concern that House language calling for open access violates the separation of congressional funding and authorization functions.

You may also be interested in...



NIH "Open Access" Plan Should Be Cooperative Venture With Publishers – NAS

The National Institutes of Health's proposal to make journal articles freely available six months after publication should maintain the credibility and authority of the peer review system, the Council of the National Academy of Sciences says.

Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s

Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058305

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel